Carlos Romo, MD
Johns Hopkins University
2
2
1
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Mary Kay Koenig, MD
The University of Texas Health Science Center, Houston
Shared therapeutic areas:
Staci M Peron, Ph.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Kavita Sarin, MD PhD
Stanford University
Shared therapeutic areas:
Worked with same sponsors:
Jaishri Blakely, MD
Johns Hopkins University
Shared therapeutic areas:
Worked with same sponsors:
Ana-Maria Vranceanu, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Barbara B Biesecker
National Human Genome Research Institute (NHGRI)
Shared therapeutic areas:
Douglas R Stewart, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
AeRang Kim, MD, PhD
Children's National Research Institute
Shared therapeutic areas:
Roger J. Packer, MD
Children's National Research Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1
All 2 trials loaded